News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

R-Tech Ueno: Basic Agreement on the Licensing of Data of Recombinant Human Serum Albumin



10/19/2011 10:21:29 AM

TOKYO--(BUSINESS WIRE)--R-Tech Ueno (JASDAQ:4573) and the Chemo-Sero-Therapeutic Research Institute (hereinafter referred to as Kaketsuken) reached basic agreement today on the licensing of data of recombinant human serum albumin as described below:

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES